MMP (USA), Inc. is pleased to announce that Scioderm a privately held, clinical-stage pharmaceutical company focused on developing topical products to address critical medical needs in the treatment of chronic skin diseases, will be featured on 21st Century Television.
Boca Raton, FL -- (SBWIRE) -- 01/17/2014 -- This 21st Century Television feature story will focus on Epidermolysis Bullosa (EB), a rare genetic connective tissue condition that, in all of its forms, share the prominent manifestation of extremely fragile skin that blisters or tears with the slightest friction or trauma. This particular manifestation has led to EB patients being known as "Butterfly children" due to the analogous nature of the fragility of the skin to the wings of a butterfly. As of today there is no cure or effective treatment. Daily wound care, pain management and preventative bandaging are the only options available for caregivers, who are usually the parents or other family members. The more severe forms of the disease lead to scarring, disfigurement, disability and early death, usually before the age of 30.
JL Haber, Vice President of Programming at MMP (USA), Inc., added “ We are very pleased to feature Scioderm on 21st Century Television. They are a progressive company that is making significant progress in the development of a potential therapy for a very rare condition.”
For airing schedule click link: http://www.tvbusinessnews.com/jan-14-clearance/21ctv2608-AP.pdf
The core business focus of Scioderm is the development of innovative dermatological drugs.
Our strategy is to in-license or acquire early to mid-stage pharmaceutical products with the intent to develop the topical products. The Scioderm team will evaluate the target assets and execute the agreements and necessary strategy to support in- and out-licensing, acquisition, strategic alliance and equity investment transactions
The Scioderm team targets assets and prepares and implements the optimum strategy to develop these products for commercial success. The team will continually seek new opportunities for in-license or partnering, interested in opportunities that have a well-validated target, a novel mechanism of action, well-characterized pharmaceutical properties, a strong intellectual property position and preclinical or clinical data.
For more information visit http://www.sderm.com
About 21st Century Television
21st Century Television is an award winning business show that is independently produced by MMP (USA), Inc. The show provides its business viewers an in depth opportunity to find solutions to the industry problems from some of the top business leaders from across the world. With more than 5000 companies participating on over 500 shows, 21st Century Television continues to be the premier and targeted outlet for the latest business stories. 21st Century Television airs on cable networks that reach over 100 million viewers worldwide. For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit http://www.tvbusinessnews.com
Distributed by 21st Century Television